UPDATE: JPMorgan Downgrades Intersect ENT (XENT) to Neutral
Tweet Send to a Friend
(Updated - November 2, 2016 10:38 AM EDT)
JPMorgan downgraded Intersect ENT (NASDAQ: XENT) from Overweight to Neutral with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
JPMorgan downgraded Intersect ENT (NASDAQ: XENT) from Overweight to Neutral with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
